FAX

T-850
t3018270003
From-FDA
s’ Oct.-22-2002 05:44pm
P. 002/005
F-340
3616 International Court NW
Washington DC 20008
Tel: (202) 672-971019734
Fax (202) 5728782
FAX
lo:
Froth: Seng Foo Wang
E-mall: eerols.com
Mr Matthew Eckd
Office of InternaUonal Programs
Food and Drug Administration
Fax:
301 - 627 0003
Pages; 4
Phone:
361- 827 0807
Date: October l&2002
C.C. MS Julia Ho, Director for Asia and Pacific, US FDA (Fax: 3MBioterrorism
927 0033)
Act 2002
We are pleased to forward herewith a COKBVof tie letter from Hon. Rafidah
Arir the Minister of International
Trade and lndustw
of Mal_avsia to Hon.
Ambassador
Zoel&
the USTR outlining Malavsia’s concerns
on vdoue
aspects of the Bioterroristn
Act 2002 whi.ch can have serious imolications
on Malavsia’s food CtXbOrtS to the United States of America
IWalayaia understands
the need for the Biotsrrorism
Act. However,
in
developing the regulations
to implement the Acf it is our hope that the US
Administration
oaticularlv
thb FDA and the Denarbnent
of Health and
Human Services would address the s~eclfic areas of Goncarn raised by
Malaysia.
The Embassy
of MalaysPia is particularhr
anpretlative..
of the recea
~~ortunitv to DarticiDate in the FDA discussions
with tireinn
embassies
&d stakeholders.
We certainly
look forward to future consultations
and
discussions
with the FDA in flnaliring
the guidelines
and regulations
in
implementing
the Act
Thank YOU,
I
cap
10/22/2002
TUE 16:56
[TX/RX NO 65591 @lo02
L
oc t.-22-2002 0 5: 4 5 p m
4.
’
_ .
T-350
t3016270003
From-FDA
f’. 0 0 3 / 0 0 5 F - 3 4 0
I
.
. .
1 w o u ld like to & a w your a tte n tio n to th e B Io te n o r l s n ~ A ti
s l g n e d b y P r e s i d e n t B u a r h In J u n e 2 0 0 2 . I a tn ~ o n & e ~ e d
w ith th e u l e m e n ta tio n
o f th e A ct th a t m a y h a v e serious
& # k a tio n s
o n N lalaysfa % fo o d e x p o r ts to th e Urlited
S ta te s .
M a taysla%
2.
concerq
o n rpeciflc
sectio n s
o f th e
’
Act
Include:
L
& tJ&
3 0 3 - T h e d u m ticm a f d e te n tio n o f i m p o m d
g o o d s s h o u l d b e a s shart a s p o s s tb l e to a v q i d
a d d i tto n a l c o & s a n d d e l a y e d e n try o f p r o d u c ts into
th e U S m a r k e t
i9. & + cti~ n 3 0 4 - T h e d e b a r r e d U S fo o d i m p o r ters s h o tA
b e m a d e k n o w n to M a laysian ~ ~ o rte =
to a v o l d
d e te n tio n o f s h i p m e n ts.
.
10/22/2002
TUE 16:56
[TX/RX N O 6 5 5 9 1 kti003
act-22-2002
.I
05:45~m
From-FDA
t3018270003
T-350
P.004/005
F-340
_
.
.
.
10/22/2002
TUE 16:56
[TX/RX NO 65591 @IO04
1
Ott-22-2002
05:45pm
From-FDA
T-850
t3018270003
P. 005/005
F-340
a’
c
the need for the BiObrrOrbm
should
not impede trade
betwem our two countries.
ComIWat@d and j3xWivek
’strict inspectIon process would affbct the cawvoetfthr@n~
of Malay&m producb and may disqpane US tradem from
4.
IVlalsysSa understands
Act
2002.
However,
the
Act
ImpMing MalaysIan products.
I--.,
5.
I hdpe the United Sates would consider
concerns and ensum that the lmplemfwrtdion
bade and @J timer
Ma,~ys$‘s
of the Ati
tachiyg to lntwnatlona1
mat of dohg
business
hrv0 countries.
10/22/2002
b&menI
TUE 16:56
our’
,
[TX/RX NO 65591 kilo05